Tekla Life Sciences Investors carries a market capitalization of 602.99M, placing it among publicly traded companies globally.
| Market Cap | 602.99M |
| Enterprise Value | N/A |
Tekla Life Sciences Investors's stock has gained approximately 52.42121% over the past 52 weeks. The 50-day moving average sits at 18.39, while the 200-day moving average is 17.26.
| Beta (5Y) | N/A |
| 52-Week Price Change | 52.42121% |
| 50-Day Moving Average | 18.39 |
| 200-Day Moving Average | 17.26 |
| Average Volume (20 Days) | N/A |